|

Chemotherapeutic Agent Clinical Trials

1 actively recruiting trial across 1 location

Also known as: COG-V/C, Carboplatin, SIOPe-LGG-V/C, VBL

Pipeline

Phase 3: 1

Top Sponsors

  • Day One Biopharmaceuticals, Inc.1

Indications

  • Pediatric Low-grade Glioma1
  • Rapidly Accelerated Fibrosarcoma (RAF) Altered Glioma1
  • Low-grade Glioma1
  • Cancer1

Birmingham, Alabama1 trial

DAY101 vs. Standard of Care Chemotherapy in Pediatric Participants With Low-Grade Glioma Requiring First-Line Systemic Therapy (LOGGIC/FIREFLY-2)

Children's of Alabama

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.